Stock Events

Stock Events

United Laboratories International 

$1.32
3
+$0.02+1.54% Thursday 18:29

Statistics

Day High
1.32
Day Low
1.32
52W High
2.28
52W Low
1.18
Volume
-
Avg. Volume
-
Mkt Cap
2.4B
P/E Ratio
8.13
Dividend Yield
4.66%
Dividend
0.06

Upcoming

7
JUL
Dividend Ex
Estimated
 
23
JUL
Dividend Payment
Estimated
 
25
SEP
Dividend Ex
Estimated
 
15
OCT
Dividend Payment
Estimated
 
8
JUL 27
Dividend Ex
Estimated
 

Dividends

4.66%Dividend Yield
Oct 25
$0.02
Jul 25
$0.04
Jul 25
$0.02
Oct 24
$0.02
Jul 24
$0.04
10Y Growth
N/A
5Y Growth
27.15%
3Y Growth
19.26%
1Y Growth
N/A

Earnings

24MarExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0.01
0.06
0.11
0.16
Expected EPS
0.00738359808
Actual EPS
0.01353659648

Financials

19.33%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.78BRevenue
729.86MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ULIHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap156.77B
Pfizer Inc. is a major global pharmaceutical company that competes in various therapeutic areas similar to United Laboratories.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. offers a broad range of pharmaceutical products that directly compete with United Laboratories in multiple markets.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson operates in the pharmaceuticals sector, providing similar products and competing in similar markets as United Laboratories.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline plc is a competitor due to its extensive range of pharmaceutical products that overlap with United Laboratories' product line.
Novartis
NVS
Mkt Cap293.34B
Novartis AG competes with United Laboratories in the development and marketing of drugs in various therapeutic areas.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie Inc. competes in the pharmaceutical industry, offering products in areas like immunology and oncology, similar to United Laboratories.
Sanofi
SNY
Mkt Cap115.14B
Sanofi operates globally in the pharmaceutical sector, competing directly with United Laboratories in several therapeutic categories.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol-Myers Squibb Company offers a wide range of pharmaceutical products that compete with United Laboratories' offerings.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca PLC has a significant presence in the pharmaceutical industry, competing in similar therapeutic areas as United Laboratories.
Roche
RHHBY
Mkt Cap330.22B
Roche Holding AG competes with United Laboratories through its comprehensive drug portfolio and global market presence.

About

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
Show more...
CEO
Mr. Hoi Shan Tsoi
Employees
17000
Country
Cayman Islands
ISIN
KYG8813K1085

Listings

STU
DE
UNJ.STU
F
DE
UNJ.F
HK
HK
3933.HK
OTC Link
US
ULIHF

0 Comments

Share your thoughts

FAQ

What is United Laboratories International stock price today?▼
The current price of ULIHF is $1.32 USD — it has increased by +1.54% in the past 24 hours. Watch United Laboratories International stock price performance more closely on the chart.
What is United Laboratories International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange United Laboratories International stocks are traded under the ticker ULIHF.
What is United Laboratories International market cap?▼
Today United Laboratories International has the market capitalization of 2.4B
When is the next United Laboratories International earnings date?▼
United Laboratories International is going to release the next earnings report on August 27, 2026.
What were United Laboratories International earnings last quarter?▼
ULIHF earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.01 USD resulting in a +83.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is United Laboratories International revenue for the last year?▼
United Laboratories International revenue for the last year amounts to 3.78B USD.
What is United Laboratories International net income for the last year?▼
ULIHF net income for the last year is 729.86M USD.
Does United Laboratories International pay dividends?▼
Yes, ULIHF dividends are paid semi-annual. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 4.66%.
How many employees does United Laboratories International have?▼
As of April 21, 2026, the company has 17,000 employees.
In which sector is United Laboratories International located?▼
United Laboratories International operates in the Health & Wellness sector.
When did United Laboratories International complete a stock split?▼
United Laboratories International has not had any recent stock splits.
Where is United Laboratories International headquartered?▼
United Laboratories International is headquartered in Yuen Long, Cayman Islands.